Aflac Faculty Position in Immune Dysregulation

Overview

Emory University is a leading research university that fosters excellence and attracts world-class talent to innovate today and prepare leaders for the future. We welcome candidates who can contribute to the excellence of our academic community.

Description

The Aflac Cancer & Blood Disorders Center of Children’s Healthcare of Atlanta and the Emory University Department of Pediatrics invite applications for a faculty position in Immune Dysregulation at the Assistant or Associate Professor level.The Immune Dysregulation Program is among the nation’s leading programs dedicated to the evaluation, diagnosis, and treatment of immune dysregulation, hyperinflammatory, and multisystem autoimmune disorders, including very early onset and treatment-refractory autoimmunity. The program integrates expertise from hematology/oncology, allergy/immunology, rheumatology, infectious diseases, gastroenterology, and intensive care in a truly multidisciplinary model, supported by a dedicated genetic counselor and program coordinator.

Position Description

We seek a clinician with fellowship training and board certification or eligibility in either Pediatric Hematology-Oncology, Allergy/Immunology, Rheumatology, or Infectious Disease, who is passionate about advancing care for children and young adults with immune dysregulation disorders.

The successful candidate will join a vibrant interdisciplinary team with established collaborations across clinical divisions at Children’s Healthcare of Atlanta. This is a clinical faculty position, and research commitment is flexible depending on the candidate’s experience and interests. Academic rank and track will be commensurate with experience and qualifications.

Program Highlights

• One of the largest clinical and translational programs in immune dysregulation in the U.S., with >1,100 patients in follow-up and 250–300 new referrals per year.
• Comprehensive evaluation and management of patients with disorders including but not limited to HLH, refractory immune cytopenias, atypical lymphoproliferation, immune-oncology, immunohematology disorders, very early-onset and refractory IBD, refractory rheumatologic disease, IEI being considered for HSCT, and neuroinflammatory disorders.
• A dedicated CRISIS Team (Critical Dysregulation of the Immune System in Sick Kids), a multidisciplinary initiative focused on early identification, management, and research in severe immune dysregulation or hyperinflammatory syndromes (e.g., HLH, MAS, immune-mediated organ failure) in critically ill patients.
• In collaboration with Neuroimmunology program we have a Neuro-CRISIS team to improve care of acute neuroinflammatory disorders.
• One of the largest HSCT programs for immune dysregulation disorders and IEI in the U.S
• A robust biorepository of over 1,000 subjects, enabling high-impact translational and biomarker discovery studies.
• Ten active clinical trials, including targeted therapies, gene therapy, and cell-based therapy studies (CAR-T and other immune-modulating approaches) for immune dysregulation disorders an
• IEI, with robust clinical and translational research infrastructure.
• Established collaborations with multiple subspecialties, including Allergy/Immunology, Rheumatology, Gastroenterology, Critical Care, Hepatology, Pulmonology, Nephrology, Dermatology, and Neuroimmunology.
• Active participation in national research networks, including PIDTC.
• Ongoing development of a Southeast Immune Dysregulation Consortium and a planned Immune Dysregulation Fellowship Program.

Responsibilities

• Provide inpatient and outpatient care for children and young adults with complex immune dysregulation disorders.
• Mentor trainees and contribute to medical education at the fellowship and residency levels.
• Participate and lead developing SOP, protocols and tool kits for screening, evaluation and management of different aspects of care of immune dysregulation disorders.
• Participate in program outreach activities.
• Participate in/ develop investigator-initiated and multi-center clinical trials.
• Develop and lead clinical or translational research projects in immune dysregulation, cellular therapy, or immunogenetics.

Institutional Strengths

• The Aflac Cancer & Blood Disorders Center is one of the largest pediatric hematology/oncology programs in the nation, caring for over 9,000 children annually and performing approximately 80 stem cell transplants each year.
• In 2024, Aflac investigators received over $30 million in extramural funding, including $17 million from the NIH.
• Emory University, Georgia Institute of Technology and Centers for Disease Control and Prevention provide unparalle